NASDAQ:RIGL

Rigel Pharmaceuticals Stock Forecast

etoro logo Buy RIGL
*Your capital is at risk
$29.93
-0.320 (-1.06%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of RIGL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RIGL to Watchlist?
Some Reasons Why To Add RIGL:
  • High gross margin of 93.4%
  • Strong operating margin of 41.6%
  • Healthy interest coverage ratio of 18.1x
PDF

Rigel Pharmaceuticals stock downgraded to Hold/Accumulate
(Updated on Jun 05, 2026)

Buy or Hold candidate since Jun 02, 2026 Loss -0.30%

The Rigel Pharmaceuticals stock price fell by -1.06% on the last day (Friday, 5th Jun 2026) from $30.25 to $29.93. During the last trading day the stock fluctuated 3.19% from a day low at $29.74 to a day high of $30.69. The price has risen in 6 of the last 10 days and is up by 2.54% over the past 2 weeks. Volume has increased on the last day by 268 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 498 thousand shares were bought and sold for approximately $14.91 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.36% during the next 3 months and, with a 90% probability hold a price between $29.81 and $37.71 at the end of this 3-month period.

RIGL Signals & Forecast

The Rigel Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $30.13. On a fall, the stock will find some support from the long-term average at approximately $29.60. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -1.84%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Rigel Pharmaceuticals stock

Rigel Pharmaceuticals finds support from accumulated volume at $29.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.95 between high and low, or 3.19%. For the last week, the stock has had daily average volatility of 4.62%.

Our recommended stop-loss: $28.93 (-3.35%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (RIGL) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Rigel Pharmaceuticals to open at $30.12, and during the day (based on 14 day Average True Range), to move between $29.21 and $30.65, which gives a possible trading interval of +/-$1.45 (+/-4.95%) up or down from last closing price. If Rigel Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $30.47 (1.80%) than the support at $29.37 (1.87%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rigel Pharmaceuticals stock A Buy?

Rigel Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.708 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $30.12 ( 0.635%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RIGL Performance

Trading levels for RIGL

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 31.07 3.81%
R2 30.71 2.60%
R1 30.48 1.85%
Price 29.93
S1 29.76 -0.578%
S2 29.53 -1.33%
S3 29.17 -2.54%

Accumulated Volume Support & Resistance Levels

Level Price
R3 32.13 7.35%
R2 30.51 1.94%
R1 30.47 1.80%
Price 29.93
S1 29.37 -1.87%
S2 29.20 -2.44%
S3 26.67 -10.89%

FAQ

What is the symbol for Rigel Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Rigel Pharmaceuticals is RIGL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rigel Pharmaceuticals Stock?
Rigel Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Rigel Pharmaceuticals Stock?
Rigel Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rigel Pharmaceuticals Stock.

What's the current price of Rigel Pharmaceuticals Stock?
As of the end of day on the Jun 05, 2026, the price of an Rigel Pharmaceuticals (RIGL) share was $29.93.

What is the 52-week high and low for Rigel Pharmaceuticals Stock?
The 52-week high for Rigel Pharmaceuticals Stock is $52.06 and the 52-week low is $18.14.

What is the market capitalization of Rigel Pharmaceuticals Stock?
As of the Jun 05, 2026, the market capitalization of Rigel Pharmaceuticals is 553.767M.

When is the next earnings date for Rigel Pharmaceuticals?
The upcoming earnings date for Rigel Pharmaceuticals is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT RIGEL PHARMACEUTICALS
Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical t...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
FIZZ
$34.11
7.04% May 01
W
WCLD
$27.34
17.78% Apr 29
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE